Doximity Announces Telehealth Deployment to Hospitals

Doximity Dialer makes it easy for physicians and patients to use their own devices for telehealth.

Doximity, the well-known digital platform for medical professionals, announced that 150 U.S. health systems have deployed Doximity Dialer Enterprise as a hospital-wide telehealth solution. Dialer enables doctors and other healthcare professionals to securely call or video chat patients directly from their own smartphones. The HIPAA-compliant tool works with any smartphone, and doesn’t require any additional setup for patients, making it easy for physicians to engage with their patients especially as telehealth makes a space for itself in the healthcare system’s new normal.

Doximity Dialer is now being used by some of the leading hospitals in the U.S., including Loma Linda University Health. “Dialer Enterprise helps us expand access to care and improve overall clinical experience for patients,” said Dr. Ricardo Peverini, a physician at the hospital. “The ability to send a video link to patients by text message ensures patients can access their visit easily and their appointment will not be missed.”

Syneos Is Bringing Trials to the Patient

Many life sciences companies are realizing the importance of making clinical trials more accessible and Syneos Health, is no exception. They’ve partnered with Medable, the leading cloud platform for patient-centered drug development, to bring new, decentralized clinical trial capabilities to Syneos. Their aim is to increase diversity in clinical trials and make them more accessible and convenient for a larger patient audience, transforming the way biopharmaceutical products are developed.

Medable’s digital platform simplifies the patient journey, and collects previously difficult to obtain data to speed therapies to patients across the clinical development lifecycle. With this platform powering the collaboration, the companies will design customized, decentralized digital solutions to Syneos Health customers tailored to the specific attributes and requirements for conducting non-interventional research.

Regeneron Expands in New York

Regeneron’s corporate headquarters in Tarrytown, NY.

Regeneron is cashing in after last year’s successful COVID-19 antibody therapy brought in $146 million in Q4 2020. Back in 2015, the company developed plans to build a factory near its headquarters in Tarrytown, NY, which would have cost $150 million. Now, they’ve upgraded the manufacturing plans to cost $480 million, according to reports in Westfair & Fairfield County Business Journals. The preclinical manufacturing and process development will also allow the Regeneron employee base to grow by at least 300 people. Regeneron’s growth is not about to stop anytime soon. It’s already made a deal with the U.S. to deliver up to 1.25 million doses of its antibody combo, which has the potential to earn them $2.63 billion.

Face2Face Is Fighting Vaccine Hesitancy

A coalition of health-specialty marketing agency principals, creatives, and healthcare workers on the front lines have formed a nationwide, community-driven COVID-19 vaccine education initiative. Face2Face America currently includes executives from Convergence Point Media, Fishawack Health, Dramatic Health, Mint Collective, SML Advisory Partners, Nestacor, and Blockboard as well as vaccine commercialization expert Jeremy Gowler of Sandoz and physician KOLs Drs. Anita Jackson and Telva Olivares.

Face2Face intends to educate vaccine hesitant Americans through a digital marketing campaign featuring interviews with community members and doctors sharing their vaccination experiences. Their focus is on communities with a large percentage of people who remain vaccine hesitant such as African-Americans, Latinos, and politically conservative Americans.

“We created Face2Face America to let these communities hear directly from their community peers and their doctors about the importance of getting vaccinated,” said Marc Benjamin, CEO of Convergence Point Media and a founder of Face2Face. “We need to expand our efforts and we are calling on our partners in the healthcare industry to get involved in our project.”

Digital media distribution partners, health endemic networks, creators, influencers, and other interested parties can sign up on the Face2Face website.


You May Also Like

2020 Pharma Choice Sales Aid Silver Winner ValueLabs and ACTO

ValueLabs and ACTO ACTO Omnichannel Education and Engagement for Life Sciences At ACTO, before ...

Healthcare Watch July/August 2019

Therapeutic Talk: Protein Therapy for Emerging Virus VEE Launched Aalto Bio, a biotech company ...

Reaching Prescribers Where Their Eyes Are—In the EHR

Among the tectonic shifts created by the pandemic is an increase in patient touchpoints, ...